A next-generation hybrid collagen biostimulator from South Korea, combining PDLLA with non-cross-linked hyaluronic acid for both immediate hydration and long-term collagen stimulation.
Unlike conventional hyaluronic acid fillers that primarily replace lost volume, JUVELOOK combines Poly-D,L-Lactic Acid (PDLLA) with non-cross-linked hyaluronic acid to provide both immediate hydration and long-term collagen stimulation. It's often described as a hybrid biostimulator or hybrid skin booster, rather than a traditional dermal filler, and has expanded into Asia, Europe, Australia, and other aesthetic markets.
85% Poly-D,L-Lactic Acid (PDLLA) with 15% non-cross-linked hyaluronic acid. Unlike cross-linked HA fillers that mainly occupy space, the PDLLA acts as a scaffold that gradually stimulates fibroblasts to produce new collagen, while the HA component provides an initial hydrating and subtly volumizing effect as the PDLLA delivers progressive skin remodeling.
Uniform, spherical PDLLA microspheres with a porous, reticular internal structure give high biocompatibility, predictable biodegradation, and a reduced inflammatory response. The porous structure increases the surface area interacting with surrounding tissue, supporting sustained collagen production.
Fine wrinkles, enlarged pores, acne scars, texture, under-eye rejuvenation — superficial to mid dermis
Cheek, temple, and jawline volume restoration with larger PDLLA particles — deeper tissue layers
A typical treatment course consists of 2–3 sessions, 4–8 weeks apart, with maintenance every 12–18 months depending on the indication and patient response. Because collagen production is gradual, full results may take 2–6 months to become apparent.
Because these risks exist with any injectable or energy-based treatment, procedures should only be performed by trained, licensed medical professionals with expertise in facial anatomy.
JUVELOOK is approved and marketed in South Korea and distributed in numerous international markets. Regulatory status differs by country, so practitioners ensure the product is authorized by the relevant national health authority before use.
JUVELOOK occupies a unique position between traditional HA fillers and collagen biostimulators such as PLLA-based products. Its hybrid PDLLA + non-cross-linked HA formulation delivers an initial hydrating effect while progressively stimulating collagen production, making it particularly effective for improving skin quality, acne scars, enlarged pores, and subtle volume loss. Compared with conventional HA fillers, the aesthetic changes are more gradual and rely on the body's natural tissue remodeling rather than immediate volumization.
